-
Mashup Score: 0ASTRO 2023: Exploring the Potential for SBRT - 7 month(s) ago
Martin King, MD, PhD, offers insights on SBRT’s potential to redefine treatment in prostate and renal cancer.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Quality Training Program | ASCO Practice Central - 7 month(s) ago
Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®). ASCO’s Quality Training Program (QTP) is a six-month course designed to help your practice improve the quality of cancer care delivery. The course elevates medical and non-medical staff members of the care team into higher-functioning quality improvement teams, identifies practice-specific areas for development, and gives you the tools and strategies necessary to make change. We
Source: practice.asco.orgCategories: Latest Headlines, Partners & KOLsTweet-
Applications are open for the ASCO Quality Training Program (QTP) winter session! Learn a #qualityimprovement method based on data and receive coaching from ASCO experts along the way. Apply here: https://t.co/aKfAh2nPtO #OncTwitter https://t.co/VMmX4SuaLC
-
-
Mashup Score: 0AI Detects Hidden, Potentially Curable Pancreatic Cancers - 7 month(s) ago
An artificial intelligence model shows potential for detecting early-stage pancreatic cancer on scans of asymptomatic individuals at a stage when surgical cure is possible.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet-
An artificial intelligence model shows potential for detecting early-stage #pancreaticcancer on scans of asymptomatic individuals at a stage when surgical cure is possible. #OncTwitter https://t.co/jFwJEob2RO
-
-
Mashup Score: 0AI Detects Hidden, Potentially Curable Pancreatic Cancers - 7 month(s) ago
An artificial intelligence model shows potential for detecting early-stage pancreatic cancer on scans of asymptomatic individuals at a stage when surgical cure is possible.
Source: www.medscape.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An AI model shows potential for detecting early-stage #pancreaticcancer on scans of asymptomatic individuals at a stage when surgical cure is possible. #OncTwitter https://t.co/tmTOEaTjII
-
-
Mashup Score: 1FDA Approves Adjuvant Nivolumab for Resected, Stage IIB/C Melanoma - 7 month(s) ago
Based on findings from the phase 3 CHECKMATE-76K trial, the FDA has approved nivolumab in the adjuvant setting for patients 12 and older with completely resected stage IIB/C melanoma.
Source: www.hmpgloballearningnetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI: The @US_FDA has approved adjuvant #nivolumab for resected, stage IIB/C melanoma. Learn more: https://t.co/Hk7mQpy6kk #medtwitter #onctwitter https://t.co/oc3i5BxSmA
-
-
Mashup Score: 0Renal Cell Carcinoma: 5 Things to Know for Primary Care - 7 month(s) ago
Cues and clues to renal cell cancer might be found in modifiable or innate patient factors. These 5 things to know for primary care might tip off timely testing or a potentially life-saving referral.
Source: www.medscape.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
➡️ Here are 5️⃣ things that primary care clinicians should know about the epidemiology, risk factors, and comorbidities of #RCC. #OncTwitter https://t.co/0XBklDSC2c https://t.co/7gJg47kFi9
-
-
Mashup Score: 0Prostate Cancer MRI Scan Quality Boosted by 'Simple' Steps - 7 month(s) ago
Researchers said improvements to MRI diagnostic quality could make a big difference to prostate cancer detection for ‘very little effort and cost’.
Source: www.medscape.co.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Prostatecancer MRI scan quality boosted by 'simple' steps #OncTwitter https://t.co/Dp9xtOS4yx https://t.co/pZHicAm1M8
-
-
Mashup Score: 0ESMO 2023: A Wealth of New Data Across Cancer Types - 7 month(s) ago
The march of immunotherapy into a wider range of malignancies, as well as the smarter use of chemotherapy and novel targeted drugs, will be among the key highlights at the ESMO Congress 2023.
Source: www.medscape.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The march of immunotherapy into a wider range of malignancies, as well as the smarter use of chemotherapy and novel targeted drugs, will be among the key highlights at the #ESMO23. #OncTwitter https://t.co/ZiD1cpBYUi
-
-
Mashup Score: 0ASTRO 2023: Exploring the Potential for SBRT - 7 month(s) ago
Martin King, MD, PhD, offers insights on SBRT’s potential to redefine treatment in prostate and renal cancer.
Source: www.medscape.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📽️ Martin King, MD, PhD, offers insights on #SBRT's potential to redefine treatment in prostate and renal cancer. #ASTRO23 #OncTwitter #RadiationTherapy https://t.co/BBKoKBEjIX https://t.co/M5C9Z7eLI3
-
-
Mashup Score: 0
At the Great Debates & Updates in Lung Cancer meeting Corey Langer, MD, discussed the therapeutic landscape for underserved patients with non-small cell lung cancer — elderly patients, and patients with ECOG performance status 2.
Source: www.hmpgloballearningnetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At #GDULC2023, @CoreyLangerMD, discussed the therapeutic landscape for underserved patients with non-small cell lung cancer — elderly patients, and patients with ECOG performance status 2. Learn more: https://t.co/i24QGu5OMS #medtwitter #onctwitter https://t.co/ebVlpciDQj
-
📽️ Martin King, MD, PhD, offers insights on SBRT's potential to redefine treatment in prostate and #renalcancer. #ASTRO23 #OncTwitter #RadiationTherapy #ProstateCancer https://t.co/lSWpLsm1LT https://t.co/CAoEUlbGeN